Subclinical hypothyroidism and the prevalence of the metabolic syndrome

Hormone and Metabolic Research

Volumn 43, Issue 6, 2011, Pages 417-421

  Liu, C ^a   Scherbaum, W A ^b   Schott, M ^b   Schinner, S ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

metabolic syndrome; subclinical hypothyroidism; thyroid; TSH

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THYROID FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHINA; DEMOGRAPHY; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 79957801822     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1275719     Document Type: Article

References (24)

1. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010 375 181-183
2. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 2005 149 33-45 (Pubitemid 40126488)
3. Garber AJ. The metabolic syndrome. Med Clin North Am 2004 88 837-846, ix (Pubitemid 39090341)
4. Lewis JG, Borowski KK, Shand BI, George PM, Scott RS. Plasma sex hormone-binding globulin, corticosteroid-binding globulin, cortisol, and free cortisol levels in outpatients attending a lipid disorders clinic: a cross-sectional study of 1137 subjects. Horm Metab Res 2010 42 274-279
5. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician 2005 72 1517-1524 (Pubitemid 43093403)
6. Kvetny J, Wilms L, Pedersen PL, Larsen J. Subclinical hypothyroidism affects mitochondrial function. Horm Metab Res 2010 42 324-327
7. Monzani F, Dardano A, Caraccio N. Does treating subclinical hypothyroidism improve markers of cardiovascular risk? Treat Endocrinol 2006 5 65-81
8. Walsh JP, Bremner AP, Bulsara MK, Oleary P, Leedman PJ, Feddema P, Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005 165 2467-2472 (Pubitemid 41720007)
9. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007 92 491-496
10. Teixeira PF, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Melo BA, Buescu A, Costa AJ, Vaisman M. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res 2008 40 50-55 (Pubitemid 351204825)
11. Walsh JP, Bremner AP, Bulsara MK, Oleary P, Leedman PJ, Feddema P, Michelangeli V. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf) 2005 63 670-675 (Pubitemid 41779641)
12. Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocr J 2007 54 71-76 (Pubitemid 46481674)
13. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003 13 3-126
14. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002 287 356-359 (Pubitemid 34251969)
15. Zhao Z, Nie H, He H, Yan Z, Liu D, Luo Z, Ma L, Ni Y, Chen J, Jing J, Cao T, Yang H, Tepel M, Zhang W, Zhu Z. High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome. Metabolism 2007 56 1612-1619 (Pubitemid 350081042)
16. Hu XS, Guo ZR, Zhou H, Shi ZM, Wu M, Zhang J, Sun GX, Zhou ZY, Pan XQ, Yao CL. Study on the prevalence of metabolic syndrome among 3574 year-olds in Jiangsu province. Zhonghua Liu Xing Bing Xue Za Zhi 2006 27 751-756
17. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002 87 489-499 (Pubitemid 34158210)
18. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 2004 61 232-238 (Pubitemid 39093119)
19. Brabant G, Beck-Peccoz P, Jarzab B, Laurberg P, Orgiazzi J, Szabolcs I, Weetman AP, Wiersinga WM. Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol 2006 154 633-637 (Pubitemid 43810847)
20. Waise A, Price HC. The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism. Ann Clin Biochem 2009 46 93-98
21. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005 90 5483-5488 (Pubitemid 41262320)
22. Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Schofl C, Pfeiffer AF, Mohlig M. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 2010 72 696-701
23. Garduno-Garcia JJ, virde-Garcia U, Lopez-Carrasco G, Padilla Mendoza ME, Mehta R, Rellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Guilar-Salinas CA. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 2010 163 273-278
24. Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y, Chen Y, Li M, Liu H, Li C, Xue H, Li N, Yu J, Shi L, Bai X, Hou X, Zhu L, Lu L, Wang S, Xing Q, Teng W. A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens 2010 24 134-138